Synthesis of 5- (1,3,3-trisubstituted) indolinyl-N,N-dimethylcarbamates as reversible cholinesterase inhibitors
Zhang, S.S.; Ji, Q.E.
Yao Xue Xue Bao 22(2): 107-113
1987
ISSN/ISBN: 0513-4870 PMID: 3618235 Document Number: 295091
Document emailed within 1 workday
Related Documents
Tonkopiĭ, V.D. 1975: Mechanism of the hypothermic action of reversible cholinesterase inhibitors Farmakologiia i Toksikologiia 38(2): 141-144Hao, X.Y.; Qin, B.Y. 1986: Effects of soman, VX and 5-(1,3,3-trimethyl)indolinyl-N,N-dimethyl carbamate on cholinesterase isoenzymes in mouse plasma Zhongguo Yao Li Xue Bao 7(4): 303-307
Siddiqui, S.Z.; Abbasi, M.A.; Rehman, A.; Ashraf, M.; Mirza, B.; Ismail, H. 2017: Synthesis of 2-[(5-benzyl-1,3,4-oxadiazole-2yl)sulfanyl]-N-(arylated/arenylated) acetamides as antibacterial and acetyl cholinesterase inhibitors Pakistan Journal of Pharmaceutical Sciences 30(5): 1743-1751
Virk, N.Akhtar.; Rehman, A.; Abbasi, M.Athar.; Siddiqui, S.Zahra.; Rashid, U.; Iqbal, J.; Saleem, M.; Ashraf, M.; Shahid, W.; Shah, S.Adnan.Ali. 2018: Conventional versus microwave assisted synthesis, molecular docking and enzyme inhibitory activities of new 3,4,5-trisubstituted-1,2,4-triazole analogues Pakistan Journal of Pharmaceutical Sciences 31(4(Supplementary): 1501-1510
Borchert, K.; Pietsch, P.; Busch, H. 1972: Use of cholinesterase inhibitors in postoperative care Zentralblatt für Chirurgie 97(4): 111-116
Petroianu, G.A.; Moshnin, W. 2008: The history of cholinesterase inhibitors: who was Moschnin(e)? Die Pharmazie 63(4): 325-327
Ellis, J.M. 2005: Cholinesterase inhibitors in the treatment of dementia Journal of the American Osteopathic Association 105(3): 145-158
Hitzeman, N. 2006: Cholinesterase inhibitors for Alzheimer's disease American Family Physician 74(5): 747-749
Ikonomoff, S.I. 1973: Effect of cholinesterase inhibitors in hysteric stupor Münchener Medizinische Wochenschrift 115(16): 701-703
Vasenina, E.E. 2013: Cholinesterase inhibitors in the treatment of mixed dementia Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 113(7 Part 2): 98-103
Richard, E.; van Gool, W.A. 2006: Cholinesterase inhibitors in dementia: the precarious balance between efficacy and safety Nederlands Tijdschrift Voor Geneeskunde 150(10): 530-532
Natoff, I.L. 1970: Influence of the route of exposure on the acute toxicity of cholinesterase inhibitors Arhiv Za Higijenu Rada i Toksikologiju 21(4): 347-352
Balashova, E.K.; Pevzner, D.L.; Rozengart, V.I.; Sherstobitov, O.E. 1974: Determination of hydrophobic organic phosphorus cholinesterase inhibitors in the blood Laboratornoe Delo 12: 719-720
Sinforiani, E.; Banchieri, L.M.; Zucchella, C.; Bernasconi, L.; Nappi, G. 2003: Cholinesterase inhibitors in Alzheimer's disease: efficacy in a non-selected population Functional Neurology 18(4): 233-237
Graipaspong, N.; Thaipisuttikul, P.; Vallipakorn, S.A.-O. 2016: Cholinesterase Inhibitors and Behavioral and Psychological Symptoms of Alzheimer's Disease Journal of the Medical Association of Thailand 99(4): 433-440
Rösler, M. 2002: The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia International Journal of Clinical Practice. Suppl 127: 20-36
Williamson, A.M.; Sarvey, J.M. 1985: Effects of cholinesterase inhibitors on evoked responses in field CA1 of the rat hippocampus Journal of Pharmacology and Experimental Therapeutics 235(2): 448-455
Gindilis, A.L.; Kurochkin, I.N. 1998: Potentiometric electrodes for determining choline, butyrylcholine and cholinesterase inhibitors Prikladnaia Biokhimiia i Mikrobiologiia 34(3): 326-331
Leeuwin, R.S. 1984: Interactions of cholinesterase inhibitors and corticosteroids with the hypnotic effect of benzodiazepines in mice Archives Internationales de Pharmacodynamie et de Therapie 269(1): 34-41
Larsson, A. 2006: Good evidence for benefits of cholinesterase inhibitors in Parkinson dementia is still missing Lakartidningen 103(19): 1537; Discussion: 1537-1538